南京科佰生物科技有限公司
主營產品: atcc代理,ATCC細胞系,ATCC細胞株,ATCC細胞庫購買 |
聯系電話
南京科佰生物科技有限公司
主營產品: atcc代理,ATCC細胞系,ATCC細胞株,ATCC細胞庫購買 |
聯系電話
參考價 | 面議 |
更新時間:2022-11-14 17:30:31瀏覽次數:775
聯系我們時請說明是化工儀器網上看到的信息,謝謝!
CBP74162 | |
I. Background | |
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), is a highly specific vascular endothelial cell growth factor that promotes increased vascular permeability, extracellular Matrix degeneration, vascular endothelial cell migration, proliferation and angiogenesis. KDR (Kinase Insert Domain Receptor) is a Protein Coding gene. Diseases associated with KDR include Hemangioma, Capillary Infantile and Angioma, Tufted. | |
II. Introduction | |
Expressed gene: | VEGF(KDR) |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | DMEM+10%FBS+2ug/ml puromycin+200ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose Response of Recombinant Human VEGF in VEGF/KDR Effector Reporter Cells (C1C42). | |
Figure 2. Inhibition of hVEGF-Induced Reporter Activity by KDR Inhibitor in hVEGF/KDR Effector Reporter Cells (C1C42). | |
Figure 3. Inhibition of hVEGF-Induced Reporter Activity by VEGF Neutralization Ab in hVEGF/KDR Effector Reporter Cells (C1C42). | |